Target intelligence / Profile preview

Non-OGG1 messenger RNAs with seed-region complementarity

Molecular classification
Other, Messenger RNA
01

Overview

Non-OGG1 messenger RNAs with seed-region complementarity refers to a collective group of transcripts that are unintentionally targeted by RNA interference (RNAi) agents, such as siRNAs or shRNAs, originally designed to silence the 8-Oxoguanine glycosylase (OGG1) gene. This phenomenon occurs because the seed region (nucleotides 2-8) of the siRNA can bind to complementary sequences in the 3' untranslated regions (UTRs) of numerous other mRNAs, leading to their degradation or translational repression (Putzbach et al., 2017). In the context of OGG1 research, this has been identified as a significant source of experimental artifact, where observed cell death is often not due to OGG1 inhibition but rather to the simultaneous silencing of multiple essential survival genes. This mechanism is a key component of Death Induced by Survival gene Elimination (DISE), a form of off-target toxicity that poses a challenge in the development of RNAi-based therapeutics and the validation of OGG1 as a drug target (Peter et al., 2019). Consequently, these mRNAs are not considered valid therapeutic targets but are instead critical factors to account for in safety assessments and experimental design. Understanding these interactions is vital for distinguishing between true target-dependent effects and sequence-specific off-target toxicity (Hadji et al., 2014).

Other names
Off-target mRNAsSeed-matched transcriptsDISE-associated mRNAsRNAi off-targetsToxic seed transcripts
02

Mechanism of action

RNA interference (RNAi) mediated silencing via seed-region complementarity in the 3' untranslated region (UTR) of non-target transcripts (Putzbach et al., 2017).

03

Biological functions

ApoptosisOther
04

Disease associations

CancerOther
05

Safety considerations

Off-target toxicityDeath Induced by Survival gene Elimination (DISE)Unintended silencing of essential genesConfounding of experimental results in OGG1 studies
06

Interacting drugs

siOGG1

1 more in the full profile.

07

Biomarkers

Survival gene expression levelsGOLGA2 mRNA levelsPLK1 mRNA levels

Beyond the preview

Go deeper on Non-OGG1 messenger RNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-OGG1 messenger RNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call